{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:22:10Z","timestamp":1793496130431,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"am","delay-in-days":399,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.parkreldis.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T11:44:25Z","timestamp":1631619865000},"page":"142-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Tau and MAPT genetics in tauopathies and synucleinopathies"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-9544","authenticated-orcid":false,"given":"Etienne","family":"Leveille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-756X","authenticated-orcid":false,"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-234X","authenticated-orcid":false,"given":"Ziv","family":"Gan-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 3","key":"10.1016\/j.parkreldis.2021.09.008_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","article-title":"Tau and tauopathies","volume":"126","author":"Arendt","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update","volume":"8","author":"Stefanova","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","article-title":"Colocalization of tau and alpha-synuclein epitopes in Lewy bodies","volume":"62","author":"Ishizawa","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5619","key":"10.1016\/j.parkreldis.2021.09.008_bib7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","article-title":"Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases","volume":"92","author":"Espay","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib9","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","article-title":"The role of MAPT in neurodegenerative diseases: genetics, mechanisms and therapy","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.09.008_bib10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ng.193","article-title":"Evolutionary toggling of the MAPT 17q21.31 inversion region","volume":"40","author":"Zody","year":"2008","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/jmg.2005.031377","article-title":"Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration","volume":"42","author":"Pittman","year":"2005","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1508","article-title":"A common inversion under selection in Europeans","volume":"37","author":"Stefansson","year":"2005","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"issue":"Pt 3","key":"10.1016\/j.parkreldis.2021.09.008_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/aws013","article-title":"Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies","volume":"135","author":"Irwin","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajpath.2013.04.025","article-title":"Acetylated tau neuropathology in sporadic and hereditary tauopathies","volume":"183","author":"Irwin","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"24","key":"10.1016\/j.parkreldis.2021.09.008_bib17","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1021\/bi400209z","article-title":"Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies","volume":"52","author":"Ramachandran","year":"2013","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12031-011-9566-7","article-title":"Are tangles as toxic as they look?","volume":"45","author":"Spires-Jones","year":"2011","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: relevance to Parkinson's disease","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct alpha-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal dementia","volume":"35","author":"Olney","year":"2017","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-12-804766-8.00015-7","article-title":"Frontotemporal dementia","volume":"167","author":"Devenney","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrneurol.2016.14","article-title":"Parkinsonism, movement disorders and genetics in frontotemporal dementia","volume":"12","author":"Baizabal-Carvallo","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0034-1381735","article-title":"Frontotemporal lobar degeneration: a clinical approach","volume":"34","author":"Karageorgiou","year":"2014","journal-title":"Semin. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","article-title":"Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review","volume":"82","author":"Seelaar","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bpa.12486","article-title":"Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype","volume":"27","author":"Mann","year":"2017","journal-title":"Brain Pathol."},{"issue":"Pt 4","key":"10.1016\/j.parkreldis.2021.09.008_bib29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awu024","article-title":"Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia","volume":"137","author":"Mesulam","year":"2014","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.24885","article-title":"Typical and atypical pathology in primary progressive aphasia variants","volume":"81","author":"Spinelli","year":"2017","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","article-title":"The genetics and neuropathology of frontotemporal lobar degeneration","volume":"124","author":"Sieben","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","article-title":"Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau)","volume":"45","author":"Dickson","year":"2011","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: neuropathology of tauopathies: principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11138\/FNeur\/2017.32.1.007","article-title":"Recent advances in the molecular genetics of frontotemporal lobar degeneration","volume":"32","author":"Rainero","year":"2017","journal-title":"Funct. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib35","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/nan.12213","article-title":"Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging","volume":"41","author":"Ghetti","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awx328","article-title":"Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies","volume":"141","author":"Forrest","year":"2018","journal-title":"Brain"},{"issue":"Pt 4","key":"10.1016\/j.parkreldis.2021.09.008_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/brain\/awl029","article-title":"A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD","volume":"129","author":"van der Zee","year":"2006","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1531-8249(200012)48:6<939::AID-ANA17>3.0.CO;2-1","article-title":"A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies","volume":"48","author":"Spillantini","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-4886(03)00393-5","article-title":"A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy","volume":"184","author":"Grover","year":"2003","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib41","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/NEN.0000000000000248","article-title":"A novel tau mutation in exon 12, p.Q336H, causes hereditary Pick disease","volume":"74","author":"Tacik","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2012.06.019","article-title":"Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS","volume":"19","author":"Ogaki","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib43","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00415-003-1137-6","article-title":"Another phenotype of frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17) with a missense mutation of S305N closely resembling Pick's disease","volume":"250","author":"Kobayashi","year":"2003","journal-title":"J. Neurol."},{"issue":"6686","key":"10.1016\/j.parkreldis.2021.09.008_bib44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00702-007-0632-9","article-title":"Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation","volume":"114","author":"Baba","year":"2007","journal-title":"J. Neural. Transm."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2012-120160","article-title":"Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S","volume":"31","author":"Deramecourt","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"Pt 10","key":"10.1016\/j.parkreldis.2021.09.008_bib47","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/brain\/awv234","article-title":"Closing the tau loop: the missing tau mutation","volume":"138","author":"McCarthy","year":"2015","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.09.008_bib48","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.clineuro.2010.07.015","article-title":"Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia","volume":"112","author":"Momeni","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004010000333","article-title":"Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells","volume":"102","author":"Iseki","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"Pt 6","key":"10.1016\/j.parkreldis.2021.09.008_bib50","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/brain\/awh147","article-title":"Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene","volume":"127","author":"Pickering-Brown","year":"2004","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib51","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.0000000000003636","article-title":"Frontotemporal dementia with the V337M MAPT mutation: tau-PET and pathology correlations","volume":"88","author":"Spina","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.09.008_bib52","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00415-019-09414-w","article-title":"Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings","volume":"266","author":"Erro","year":"2019","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12883-017-0966-3","article-title":"Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib54","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00415-014-7456-y","article-title":"Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort","volume":"261","author":"Cohn-Hokke","year":"2014","journal-title":"J. Neurol."},{"issue":"Pt 4","key":"10.1016\/j.parkreldis.2021.09.008_bib55","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/brain\/awg090","article-title":"Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia","volume":"126","author":"Stanford","year":"2003","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.08.008","article-title":"New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization","volume":"33","author":"Rossi","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10048-005-0210-y","article-title":"Novel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia","volume":"6","author":"Neumann","year":"2005","journal-title":"Neurogenetics"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib58","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/acn3.50844","article-title":"Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia","volume":"6","author":"Borrego-Ecija","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","article-title":"Tau is a candidate gene for chromosome 17 frontotemporal dementia","volume":"43","author":"Poorkaj","year":"1998","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-006-0182-5","article-title":"The novel Tau mutation G335S: clinical, neuropathological and molecular characterization","volume":"113","author":"Spina","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib61","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/j.1468-1331.2007.01763.x","article-title":"A novel MAPT mutation (P301T) associated with familial frontotemporal dementia","volume":"14","author":"Llado","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib62","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ana.20668","article-title":"Phenotypic heterogeneity within a new family with the MAPT p301s mutation","volume":"58","author":"Yasuda","year":"2005","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.10163","article-title":"Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation","volume":"51","author":"Hayashi","year":"2002","journal-title":"Ann. Neurol."},{"issue":"2 Dementia","key":"10.1016\/j.parkreldis.2021.09.008_bib64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/CON.0000000000000300","article-title":"Frontotemporal dementias","volume":"22","author":"Finger","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib65","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/nan.12250","article-title":"Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations","volume":"41","author":"Lashley","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1750-3639.2007.00052.x","article-title":"Hereditary frontotemporal dementia caused by Tau gene mutations","volume":"17","author":"van Swieten","year":"2007","journal-title":"Brain Pathol."},{"issue":"15","key":"10.1016\/j.parkreldis.2021.09.008_bib67","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/hmg\/dds161","article-title":"Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases","volume":"21","author":"Coppola","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WAD.0b013e31828cc357","article-title":"Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease","volume":"27","author":"Lee","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp-2016-314411","article-title":"Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases","volume":"88","author":"Ferrari","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib70","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archneur.59.6.935","article-title":"Association between the extended tau haplotype and frontotemporal dementia","volume":"59","author":"Verpillat","year":"2002","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-4886(03)00024-4","article-title":"Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"181","author":"Hughes","year":"2003","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib72","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nbd.2005.11.013","article-title":"The H2 MAPT haplotype is associated with familial frontotemporal dementia","volume":"22","author":"Ghidoni","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2377-8-48","article-title":"Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland","volume":"8","author":"Kaivorinne","year":"2008","journal-title":"BMC Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib74","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.neurobiolaging.2007.02.019","article-title":"Genetic analysis of MAPT haplotype diversity in frontotemporal dementia","volume":"29","author":"Laws","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"27","key":"10.1016\/j.parkreldis.2021.09.008_bib75","doi-asserted-by":"crossref","first-page":"44994","DOI":"10.18632\/oncotarget.16690","article-title":"Meta-analysis of the association between variants in MAPT and neurodegenerative diseases","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib76","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1017\/cjn.2019.228","article-title":"Genetic variation in the ontario neurodegenerative disease research initiative","volume":"46","author":"Dilliott","year":"2019","journal-title":"Can. J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.09.008_bib77","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1001\/archneur.62.9.1419","article-title":"Association between tau H2 haplotype and age at onset in frontotemporal dementia","volume":"62","author":"Borroni","year":"2005","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2021.09.008_bib78","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1176\/appi.ajp.2007.06091456","article-title":"Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia","volume":"164","author":"Laws","year":"2007","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib79","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib80","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.parkreldis.2010.01.004","article-title":"Screening for MAPT and PGRN mutations in Korean patients with PSP\/CBS\/FTD","volume":"16","author":"Kim","year":"2010","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib81","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1212\/WNL.0b013e3181a92bcc","article-title":"Familial aggregation of parkinsonism in progressive supranuclear palsy","volume":"73","author":"Donker Kaat","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14802\/jmd.15033","article-title":"Genetics of progressive supranuclear palsy","volume":"8","author":"Im","year":"2015","journal-title":"J Mov Disord"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib83","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy","volume":"43","author":"Hoglinger","year":"2011","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib84","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamaneurol.2019.0250","article-title":"Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology","volume":"76","author":"Heckman","year":"2019","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib85","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00401-017-1693-y","article-title":"Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia","volume":"133","author":"Yokoyama","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"33","key":"10.1016\/j.parkreldis.2021.09.008_bib86","doi-asserted-by":"crossref","first-page":"34873","DOI":"10.1074\/jbc.M405131200","article-title":"Promotion of hyperphosphorylation by frontotemporal dementia tau mutations","volume":"279","author":"Alonso Adel","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib87","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.nbd.2006.10.018","article-title":"The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts","volume":"25","author":"Myers","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib88","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/mp.2015.6","article-title":"Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus","volume":"20","author":"Desikan","year":"2015","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt268","article-title":"Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels","volume":"6","author":"Allen","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.57.1.138","article-title":"Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy","volume":"57","author":"Litvan","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib91","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/mds.27198","article-title":"Cognitive impairment in progressive supranuclear palsy is associated with tau burden","volume":"32","author":"Koga","year":"2017","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib92","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.1159","article-title":"Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy","volume":"50","author":"Liu","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib93","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnen\/nlz141","article-title":"Primary tau pathology, not copathology, correlates with clinical symptoms in PSP and CBD","volume":"79","author":"Robinson","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib94","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/mds.27196","article-title":"Genetic influences on cognition in progressive supranuclear palsy","volume":"32","author":"Gerstenecker","year":"2017","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib95","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","article-title":"Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci","volume":"132","author":"Allen","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib96","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib97","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","article-title":"Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype","volume":"56","author":"Houlden","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib98","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1531-8249(200003)47:3<374::AID-ANA15>3.0.CO;2-8","article-title":"Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy","volume":"47","author":"Di Maria","year":"2000","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib99","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nbd.2008.09.027","article-title":"5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration","volume":"33","author":"Cruchaga","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib100","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1038\/ncomms8247","article-title":"Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy","volume":"6","author":"Kouri","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib101","first-page":"311","article-title":"Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy","volume":"9","author":"Kertesz","year":"2003","journal-title":"Neurol."},{"issue":"7721","key":"10.1016\/j.parkreldis.2021.09.008_bib102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick's disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.parkreldis.2021.09.008_bib103","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1873-3468.13108","article-title":"Tau filaments in neurodegenerative diseases","volume":"592","author":"Goedert","year":"2018","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib104","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-015-1502-4","article-title":"Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank","volume":"130","author":"Bieniek","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib105","article-title":"Genetics of chronic traumatic encephalopathy","author":"Abdolmohammadi","year":"2020","journal-title":"Semin. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib106","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib107","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-012-1044-y","article-title":"Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia","volume":"124","author":"Janocko","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib108","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00401-012-1017-1","article-title":"The MAPT H1 haplotype is associated with tangle-predominant dementia","volume":"124","author":"Santa-Maria","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"14","key":"10.1016\/j.parkreldis.2021.09.008_bib110","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib111","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib112","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","article-title":"Human secreted tau increases amyloid-beta production","volume":"36","author":"Bright","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2021.09.008_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0938-9","article-title":"Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease","author":"Dujardin","year":"2020","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib114","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/ajmg.b.30951","article-title":"An association study of common variation at the MAPT locus with late-onset Alzheimer's disease","volume":"150B","author":"Abraham","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.09.008_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0304-3940(01)02289-3","article-title":"The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysis","volume":"314","author":"Russ","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib116","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2156-8-3","article-title":"Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease","volume":"8","author":"Mukherjee","year":"2007","journal-title":"BMC Genet."},{"issue":"16","key":"10.1016\/j.parkreldis.2021.09.008_bib117","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/hmg\/ddi241","article-title":"The H1c haplotype at the MAPT locus is associated with Alzheimer's disease","volume":"14","author":"Myers","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib118","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.mp.4001935","article-title":"Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease","volume":"12","author":"Laws","year":"2007","journal-title":"Mol. Psychiatr."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib119","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.neurobiolaging.2009.09.004","article-title":"No replication of genetic association between candidate polymorphisms and Alzheimer's disease","volume":"32","author":"Cousin","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib121","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2011-110824","article-title":"The role of variation at AbetaPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease","volume":"28","author":"Gerrish","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2012.10.004","article-title":"An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease","volume":"34","author":"Liu","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"26","key":"10.1016\/j.parkreldis.2021.09.008_bib123","doi-asserted-by":"crossref","first-page":"43506","DOI":"10.18632\/oncotarget.16490","article-title":"The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.06.002","article-title":"Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease","volume":"35","author":"Sassi","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-017-0330-2","article-title":"Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review","volume":"10","author":"Ygland","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/humu.10269","article-title":"Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe","volume":"22","author":"Rademakers","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib127","doi-asserted-by":"crossref","unstructured":"Le Guennec K, Quenez O, Nicolas G, et al. 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Mol. Psychiatr.. 2017;22(8):1119-1125.","DOI":"10.1038\/mp.2016.226"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/WAD.0000000000000179","article-title":"Genetic comparison of symptomatic and asymptomatic persons with alzheimer disease neuropathology","volume":"31","author":"Monsell","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jnnp-2011-301413","article-title":"An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology","volume":"83","author":"Wider","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jalz.2013.02.010","article-title":"Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study","volume":"10","author":"Peterson","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"23","key":"10.1016\/j.parkreldis.2021.09.008_bib131","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1073\/pnas.0801227105","article-title":"Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition","volume":"105","author":"Kauwe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1128","article-title":"Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: a preliminary study in a Croatian cohort","volume":"8","author":"Babic Leko","year":"2018","journal-title":"Brain Behav"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib133","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","article-title":"GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease","volume":"78","author":"Cruchaga","year":"2013","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059676","article-title":"Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort","volume":"8","author":"Elias-Sonnenschein","year":"2013","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib135","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.09.008_bib136","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib137","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/mds.27385","article-title":"Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder","volume":"33","author":"Li","year":"2018","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2021.09.008_bib138","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib139","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-1331.2009.02847.x","article-title":"Association of the MAPT locus with Parkinson's disease","volume":"17","author":"Wider","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib141","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/jnnp.2003.026203","article-title":"Tau gene and Parkinson's disease: a case-control study and meta-analysis","volume":"75","author":"Healy","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib142","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/mds.20864","article-title":"Association of the Tau haplotype with Parkinson's disease in the Greek population","volume":"21","author":"Fidani","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib143","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2202-15-54","article-title":"MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China","volume":"15","author":"Yu","year":"2014","journal-title":"BMC Neurosci."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/424492","article-title":"Linkage disequilibrium and association of MAPT H1 in Parkinson disease","volume":"75","author":"Skipper","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.09.008_bib145","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2007.11.019","article-title":"Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease","volume":"30","author":"Vandrovcova","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib146","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.ejhg.5201901","article-title":"Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease","volume":"15","author":"Winkler","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib147","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ana.21157","article-title":"Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease","volume":"62","author":"Zabetian","year":"2007","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib148","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.12.006","article-title":"Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals","volume":"36","author":"Winder-Rhodes","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib149","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson's disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib151","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archneurol.2011.17","article-title":"Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes","volume":"68","author":"Seto-Salvia","year":"2011","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib152","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.09.008_bib153","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jnnp.2011.240366","article-title":"The natural history of treated Parkinson's disease in an incident, community based cohort","volume":"82","author":"Evans","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib154","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.12.008","article-title":"Phenotypic associations of tau and ApoE in Parkinson's disease","volume":"414","author":"Papapetropoulos","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2008.10.018","article-title":"Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease","volume":"448","author":"Ezquerra","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib157","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/mds.23806","article-title":"Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease","volume":"26","author":"Factor","year":"2011","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib158","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2021.09.008_bib159","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"APOE, MAPT, and COMT and Parkinson's disease susceptibility and cognitive symptom progression","volume":"6","author":"Paul","year":"2016","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib161","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00702-013-1117-7","article-title":"Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes","volume":"121","author":"Di Battista","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib162","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fncel.2016.00096","article-title":"Genetic architecture of MAPT gene region in Parkinson disease subtypes","volume":"10","author":"Pascale","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.09.014","article-title":"Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression","volume":"37","author":"Davis","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib164","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mds.27659","article-title":"Parkinson's disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms","volume":"34","author":"Blauwendraat","year":"2019","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib165","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ana.22321","article-title":"Independent and joint effects of the MAPT and SNCA genes in Parkinson disease","volume":"69","author":"Elbaz","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib166","article-title":"SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians","volume":"2015","author":"Huang","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib167","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mds.27864","article-title":"The genetic architecture of Parkinson disease in Spain: characterizing population-specific risk, differential haplotype structures, and providing etiologic insight","volume":"34","author":"Bandres-Ciga","year":"2019","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib168","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00702-016-1552-3","article-title":"The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease","volume":"123","author":"Robakis","year":"2016","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib169","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2017.09.009","article-title":"Parkinson's disease susceptibility variants and severity of Lewy body pathology","volume":"44","author":"Heckman","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.parkreldis.2021.09.008_bib171","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0000000000001946","article-title":"Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies","volume":"85","author":"Labbe","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib172","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.b.32390","article-title":"Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases","volume":"171B","author":"Cervera-Carles","year":"2016","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib173","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jalz.2016.05.002","article-title":"MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies","volume":"12","author":"Labbe","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib174","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"issue":"23","key":"10.1016\/j.parkreldis.2021.09.008_bib175","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib176","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture","author":"Chia","year":"2020","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib177","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neurobiolaging.2012.06.015","article-title":"MAPT H1 haplotype is associated with enhanced alpha-synuclein deposition in dementia with Lewy bodies","volume":"34","author":"Colom-Cadena","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib178","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Colom-Cadena","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib179","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib180","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/WNL.0b013e31820c30c1","article-title":"MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy","volume":"76","author":"Vilarino-Guell","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.09.008_bib181","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2016.06.010","article-title":"MAPT haplotype diversity in multiple system atrophy","volume":"30","author":"Labbe","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib182","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.55.12.1918","article-title":"Multiple system atrophy\/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE","volume":"55","author":"Morris","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.09.008_bib183","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/00207454.2015.1086345","article-title":"Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis","volume":"126","author":"Chen","year":"2016","journal-title":"Int. J. Neurosci."},{"issue":"15","key":"10.1016\/j.parkreldis.2021.09.008_bib184","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.09.008_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2018.03.018","article-title":"Analysis of GWAS-linked variants in multiple system atrophy","volume":"67","author":"Gu","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib186","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0304-3940(01)02190-5","article-title":"Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy","volume":"312","author":"Morris","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib187","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01376517-200212000-00005","article-title":"Parkinson-plus patients--an unknown group with severe symptoms","volume":"34","author":"Sjostrom","year":"2002","journal-title":"J. Neurosci. Nurs."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2009.09.011","article-title":"Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy","volume":"32","author":"Ezquerra","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.09.008_bib189","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/brain\/awaa097","article-title":"Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes","volume":"143","author":"Murley","year":"2020","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/hmg\/ddt451","article-title":"Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation","volume":"23","author":"Iwata","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib191","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-2012-111223","article-title":"Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex","volume":"29","author":"Bakulski","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib192","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/NEN.0b013e3181af2e46","article-title":"DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain","volume":"68","author":"Barrachina","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.09.008_bib193","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/mds.26820","article-title":"The MAPT gene is differentially methylated in the progressive supranuclear palsy brain","volume":"31","author":"Huin","year":"2016","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004211","article-title":"An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy","volume":"10","author":"Li","year":"2014","journal-title":"PLoS Genet."},{"issue":"13","key":"10.1016\/j.parkreldis.2021.09.008_bib195","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/mds.25784","article-title":"DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro","volume":"29","author":"Coupland","year":"2014","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib196","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","article-title":"Posttranslational modifications mediate the structural diversity of tauopathy strains","volume":"180","author":"Arakhamia","year":"2020","journal-title":"Cell"},{"issue":"7802","key":"10.1016\/j.parkreldis.2021.09.008_bib197","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.parkreldis.2021.09.008_bib198","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1093\/hmg\/dds238","article-title":"MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies","volume":"21","author":"Trabzuni","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib199","article-title":"Alzheimer's disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimers Dement (N Y)."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib200","article-title":"Reactions to multiple ascending doses of the microtubule stabilizer TPI-287 in patients with alzheimer disease, progressive supranuclear palsy, and corticobasal syndrome: a randomized clinical trial","author":"Tsai","year":"2019","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.008_bib201","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.2335","article-title":"Structural diversity and African origin of the 17q21.31 inversion polymorphism","volume":"44","author":"Steinberg","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib202","article-title":"Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at Chr16q11.2 and on the MAPT H1 allele","author":"Soutar","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.parkreldis.2021.09.008_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2020.07.022","article-title":"Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease","author":"Soto-Beasley","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0066-z","article-title":"LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate","volume":"11","author":"Belluzzi","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.09.008_bib205","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/acn3.50917","article-title":"De novo NSF mutations cause early infantile epileptic encephalopathy","volume":"6","author":"Suzuki","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib206","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ng.2257","article-title":"Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype","volume":"44","author":"Zollino","year":"2012","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib207","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib208","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during the course of Alzheimer disease","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.09.008_bib209","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archneurol.2009.196","article-title":"Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study","volume":"66","author":"Portet","year":"2009","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.008_bib210","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.parkreldis.2021.09.008_bib211","doi-asserted-by":"crossref","first-page":"f4827","DOI":"10.1136\/bmj.f4827","article-title":"Clinical review. Frontotemporal dementia","volume":"347","author":"Warren","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.parkreldis.2021.09.008_bib212","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2015.00171","article-title":"Phenotypic heterogeneity of monogenic frontotemporal dementia","volume":"7","author":"Benussi","year":"2015","journal-title":"Front. Aging Neurosci."},{"issue":"7\u20138","key":"10.1016\/j.parkreldis.2021.09.008_bib213","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/21678421.2015.1074700","article-title":"Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations","volume":"16","author":"Snowden","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.09.008_bib214","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/WCO.0b013e32834cd442","article-title":"Phenotypic signatures of genetic frontotemporal dementia","volume":"24","author":"Rohrer","year":"2011","journal-title":"Curr. Opin. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.09.008_bib215","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease","volume":"46","author":"Dickson","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib216","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0072-9752(07)01231-6","article-title":"Neuropathology of dementia with Lewy bodies","volume":"89","author":"Lowe","year":"2008","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib217","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1789.2010.01159.x","article-title":"Tau-positive glial cytoplasmic granules in multiple system atrophy","volume":"31","author":"Nagaishi","year":"2011","journal-title":"Neuropathology"},{"issue":"Pt 1","key":"10.1016\/j.parkreldis.2021.09.008_bib218","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.09.008_bib219","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jalz.2017.01.028","article-title":"Cognitive decline associated with pathological burden in primary age-related tauopathy","volume":"13","author":"Jefferson-George","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.09.008_bib220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/brain\/awz403","article-title":"Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy","volume":"143","author":"Teylan","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153852","article-title":"Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis","volume":"11","author":"Gasca-Salas","year":"2016","journal-title":"PloS One"},{"issue":"21","key":"10.1016\/j.parkreldis.2021.09.008_bib222","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1093\/hmg\/ddi361","article-title":"High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy","volume":"14","author":"Rademakers","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.09.008_bib223","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2006.06.032","article-title":"Effect of MAPT and APOE on prognosis of progressive supranuclear palsy","volume":"405","author":"Baba","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.09.008_bib224","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12031-011-9641-0","article-title":"The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction","volume":"46","author":"Gan-Or","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.09.008_bib225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.parkreldis.2008.10.008","article-title":"Genetic factors influencing age at onset in LRRK2-linked Parkinson disease","volume":"15","author":"Golub","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.008_bib226","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-016-1590-9","article-title":"Epigenetic regulation in Parkinson's disease","volume":"132","author":"Labbe","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2021.09.008_bib227","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-015-0025-8","article-title":"Regulation of human MAPT gene expression","volume":"10","author":"Caillet-Boudin","year":"2015","journal-title":"Mol. Neurodegener."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:24:31Z","timestamp":1761179071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021003370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":227,"alternative-id":["S1353802021003370"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tau and MAPT genetics in tauopathies and synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}